Skip to search.
 All Ordinaries Down 0.07%

More On PGL.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Progen Pharmaceuticals Ltd (PGL.AX)

-ASX
0.23 0.00(0.00%) 4 Dec 15:59
Prev Close:0.23
Open:0.22
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.20 - 0.23
52wk Range:0.14 - 0.23
Volume:68,707
Avg Vol (3m):N/A
Market Cap:28.09M
P/E (ttm):N/A
EPS (ttm):-0.09
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

As of January 29, 2016, Progen Pharmaceuticals Limited was acquired by TBG Inc., in a reverse merger transaction. Progen Pharmaceuticals Limited, a biotechnology company, discovers, researches, and develops pharmaceutical therapeutics for the tre... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback